This study will investigate the hypothesis that the combination of testosterone replacement and alendronate will improve bone density and parameters of bone quality more than either medication alone in older men with low testosterone levels and low bone density.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
44
Testosterone Gel (Fortesta) 40mg daily.
Alendronate (Fosamax) 70mg every week.
A placebo alendronate tablet will be taken every week by subjects in the Testosterone and Placebo Alendronate Group.
Massachusetts General Hospital
Boston, Massachusetts, United States
Percent Change in Spine Bone Density From Baseline to 12 Months
Percent Change in Spine Bone Density from Baseline (month 0) to Month 12
Time frame: Baseline and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Placebo testosterone gel will be applied daily by subjects in the Alendronate and Placebo Testosterone group.